Consumer Defensive Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 05/22/2026 | CALL | $25.00 | 9,625 | +2,108 | +28.04% |
| 07/17/2026 | CALL | $27.00 | 3,178 | +1,485 | +87.71% |
| 05/22/2026 | PUT | $22.00 | 5,058 | +1,253 | +32.93% |
| 11/20/2026 | CALL | $22.00 | 1,082 | +1,000 | +1,219.51% |
| 11/20/2026 | CALL | $21.00 | 1,042 | +993 | +2,026.53% |
| 01/15/2027 | CALL | $100.00 | 8,308 | +876 | +11.79% |
| 05/22/2026 | CALL | $23.50 | 1,676 | -459 | -21.50% |
| 05/22/2026 | CALL | $23.00 | 6,296 | -535 | -7.83% |
| 01/15/2027 | PUT | $13.00 | 4,398 | -552 | -11.15% |
| 05/29/2026 | CALL | $28.00 | 2,376 | -566 | -19.24% |
| 06/18/2026 | PUT | $45.00 | 204 | -585 | -74.14% |
| 01/15/2027 | CALL | $15.00 | 2,287 | -997 | -30.36% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.78% | 3.57M | 30.96M |
| Vanguard Small-Cap Index Fund | 1.54% | 3.08M | 26.72M |
| iShares Russell 2000 ETF | 1.33% | 2.66M | 23.08M |
| Vanguard Small-Cap Growth Index Fund | 0.89% | 1.78M | 15.39M |
| Franklin Strategic Series-Franklin Small Cap Growth Fund | 0.84% | 1.68M | 14.61M |
| Vanguard Extended Market Index Fund | 0.79% | 1.59M | 13.76M |
| Fidelity Small Cap Index Fund | 0.50% | 997.91k | 8.65M |
| iShares Russell 2000 Growth ETF | 0.39% | 790.2k | 6.85M |
| TIAA-CREF Funds-Quant Small Cap Equity Fund | 0.36% | 717.3k | 6.22M |
| Fidelity Extended Market Index Fund | 0.31% | 621.62k | 5.39M |
Hims & Hers Massive Stock Drop Explained
05/19 02:06 pm
The Motley Fool
Read moreHims & Hers Stock Drops After Earnings: Buying Opportunity or Warning Sign?
05/15 05:05 am
The Motley Fool
Read moreIs Hims and Hers Health Stock a Buy After Its Latest Dip?
05/14 12:30 pm
The Motley Fool
Read moreS&P 500 Valuation Looks Stretched as Inflation Reprices Rate-Cut Odds
05/13 12:22 pm
Investing.com
Read moreHims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recov
05/12 01:49 pm
Investing.com
Read moreWhy Hims & Hers Health Stock Just Crashed
05/12 11:32 am
The Motley Fool
Read moreThe $59B Quiet Shift Reshaping How Patients Access Care
05/12 10:30 am
Benzinga
Read moreGoodRx vs. Hims & Hers Health: Stagnation vs. Growth in Revenue
05/10 08:24 am
The Motley Fool
Read moreHims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus
05/08 12:20 pm
Investing.com
Read moreEXCLUSIVE: Enhanced CEO Says Its Performance Medicine Platform Is The Real Prize Beyond The Games
04/29 03:30 pm
Benzinga
Read moreSpaceX Goes on $60 Billion AI Buying Spree
04/27 05:10 pm
The Motley Fool
Read moreHims & Hers Positions Itself As Supply Anchor In Hormone Therapy Crunch
04/23 12:19 pm
Benzinga
Read more3 Sectors to Buy While They’re Down and 1 to Walk Away From
04/07 11:31 am
Investing.com
Read moreData Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data Breach
04/03 07:23 pm
GlobeNewswire Inc.
Read moreSlash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan
03/31 02:35 pm
Benzinga
Read moreIndia's Generic Wave Hits Ozempic And Wegovy As Prices Drop Sharply
03/23 09:00 am
Benzinga
Read moreNovo Nordisk Secures FDA Approval For Higher-Dose Wegovy
03/19 01:50 pm
Benzinga
Read moreLucid Tops The Most-Shorted Stock List—Here Are 9 More Short Targets
03/11 03:20 pm
Benzinga
Read moreEurope In Review: Natural Gas Prices Spike As Europe Splits Over US‑Israeli Strikes
03/10 10:47 am
Benzinga
Read moreStock Market Today: Dow, Nasdaq 100, S&P 500 Futures Plunge As Oil Prices Jump, Trump Dismisses 'Short Term' Spike— Hims & Hers In Focus (UPDATED)
03/09 09:17 am
Benzinga
Read moreHims & Hers, Novo Nordisk Weight-Loss Drug Deal Ends Legal Feud, Stock Soars
03/09 07:04 am
Benzinga
Read moreHims & Hers: The Telehealth Growth Story Younger Investors Can't Afford to Ignore
02/26 08:17 am
The Motley Fool
Read moreHims & Hers in Free Fall: Why Analysts See Nearly 150% Upside
02/24 10:35 am
Investing.com
Read moreDeal Dispatch: Starboard Targets TripAdvisor, His & Hers Expands, Mister Car Wash Goes Private
02/20 04:40 pm
Benzinga
Read moreHims & Hers Health $1 Billion Eucalyptus Acquisition Fuels Global Expansion Dreams
02/19 09:50 am
Benzinga
Read moreTop 10 Most Shorted Stocks: CleanSpark, Hims & Hers And More
02/13 04:32 pm
Benzinga
Read moreNovo Nordisk Plans Wegovy Vial Launch To Counter Eli Lilly, Target Broader Obesity Market
02/12 02:02 pm
Benzinga
Read moreStock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit
02/09 07:34 pm
The Motley Fool
Read moreHims & Hers Collapses After FDA Vows to Restrict Copycat GLP-1 Pill. Is the Stock Toast?
02/09 05:07 pm
The Motley Fool
Read moreNovo Nordisk vs. Eli Lilly: What's the Better Long-Term Investment?
02/09 03:30 pm
The Motley Fool
Read moreHims & Hers Under Fire, Stock Tanks on Federal Crackdown, Patent War
02/09 02:03 pm
Benzinga
Read moreNovo Nordisk Takes Legal Action Against Hims & Hers Over Wegovy Knock Offs
02/09 10:46 am
Benzinga
Read moreWhat's Going On With Novo Nordisk Stock On Friday?
02/06 02:51 pm
Benzinga
Read moreHims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026
02/05 09:51 pm
GlobeNewswire Inc.
Read moreAmazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.
02/05 09:15 pm
The Motley Fool
Read morePharmaZee GLP-1 Prescription Information Updated as Novo Nordisk Raises Compounding Concerns and Consumer Interest in Telehealth Semaglutide Access Grows in 2026
02/05 08:53 pm
GlobeNewswire Inc.
Read moreHims & Hers Launches Compounded Version Of Wegovy, Novo Nordisk Threatens Legal Action
02/05 01:51 pm
Benzinga
Read moreHUGE News: Hims & Hers Adds Cancer Testing to Labs Offering
02/04 12:25 pm
The Motley Fool
Read moreThese 10 Stocks Could Be Short Squeeze Targets: Lucid, Kohl's, Avis and More
02/02 03:08 pm
Benzinga
Read moreKelley Drye Expands Privacy Practice with Partner Kate Black and Special Counsel Mason Fitch
01/26 02:00 pm
GlobeNewswire Inc.
Read more2 Top Stocks to Double Up On Right Now
01/20 08:05 pm
The Motley Fool
Read moreLooking For A Short Squeeze? 10 Stocks Ready To Rocket
01/16 11:41 am
Benzinga
Read moreStocks to Love in 2026
01/12 12:04 am
The Motley Fool
Read moreTop 10 Most Shorted Stocks: Lucid, MARA, Hims and More
12/29 11:30 am
Benzinga
Read moreHigh Short-Interest Stocks to Buy Before Q1 2026
12/10 11:12 am
Investing.com
Read moreWhy Is Hims & Hers Stock Falling, and Should Investors Buy the Dip?
11/26 06:15 am
The Motley Fool
Read moreNovo Nordisk Just Took a Big Swing, Slashing Its GLP-1 Drug Prices. Will It Pay Off for the Healthcare Giant?
11/23 05:30 am
The Motley Fool
Read more